Canada Neurology Devices Investment Opportunities

This report is an essential source for in-depth information and data relating to Canada neurology devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the neurology devices in Canada

Scope

• The report provides neurology devices information broken down into detailed categories and segments in Canada.
• Total revenues, products sold, end users, and average pricing.
• Market shares of all the key competitors.
• Key pipeline products that are set to shape the market, broken down by sector.
• Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
• Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
• Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
• Key mergers and acquisitions, partnerships, private equity investments and IPOs.
• Customer, hospitals and physicians data.

Reasons to buy

• Gain a strong understanding of the neurology devices market in Canada.
• Evaluate and compare the attractiveness of the market in the country.
• Identify growth segments and opportunities in each industry sector within the country.
• Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
• Analyze the competitiveness of the market in the country and identify hotspots.
• Develop strategies based on the latest product, brand, expansion and research and development news in the country.
• Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
• Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

• 1 List of Tables
• 1.2 List of Figures
• 2 Introduction
  • 2.1 What Is This Report About?
• 3 Definitions of Markets Covered in This Report
  • 3.1 Neurology Devices
  • 3.2 CSF Management
    • 3.2.1 Hydrocephalus Shunts
    • 3.2.2 ICP Monitoring Devices
  • 3.3 Interventional Neurology
    • 3.3.1 Aneurysm Clips
    • 3.3.2 Embolic Systems
    • 3.3.3 Navigational Systems
  • 3.4 Neurostimulation Devices
    • 3.4.1 Deep Brain Stimulators
    • 3.4.2 Spinal Cord Stimulators
    • 3.4.3 Vagus Nerve Stimulators
  • 3.5 Neurosurgical Products
    • 3.5.1 Neuroendoscopes
  • 3.6 Radiosurgery
    • 3.6.1 CyberKnife Radiosurgery
    • 3.6.2 GammaKnife Radiosurgery
• 4 Healthcare Sector Review
  • 4.1 Healthcare Expenditure
  • 4.2 Healthcare Infrastructure
  • 4.3 Healthcare Policy
  • 4.4 Canada Healthcare Trade Statistics
• 5 Regulation System
  • 5.1 Medical Equipment Approval Process
    • 5.1.1 Classification
    • 5.1.2 Conformity Assessment
      • 5.1.2.1 Class II
      • 5.1.2.2 Class III
      • 5.1.2.3 Class IV
    • 5.1.3 License Fee
    • 5.1.4 License Application Processing Duration
  • 5.2 Labeling and Packaging
  • 5.3 Post-Market Surveillance
• 6 Pricing and Reimbursement
• 7 Distribution Structure
  • 7.1 Distribution Structure
• 8 Neurology Devices In Canada
  • 8.1 Neurology Devices Cross Country Comparison, Revenue ($ mn), 2000-2015
  • 8.2 Neurology Devices, Canada, Overall Revenue ($ mn), 2000-2015
  • 8.3 Neurology Devices, Canada, Category Volume (Units), 2000-2015
  • 8.4 Neurology Devices, Canada, Company Share (2006-2007)
• 9 CSF Management In Canada
  • 9.1 CSF Management Overall Revenue (2000-2015)
  • 9.2 CSF Management Overall Volume (2000-2015)
  • 9.3 CSF Management Average Price (2000-2015)
  • 9.4 CSF Management Distribution Share (2007-2008)
  • 9.5 CSF Management, Canada, Company Share (2006-2007)
• 10 Interventional Neurology In Canada
  • 10.1 Interventional Neurology Overall Revenue (2000-2015)
    • 10.1.1 Embolic Systems Revenue (2000-2015)
    • 10.1.2 Navigational Systems Revenue (2000-2015)
  • 10.2 Interventional Neurology Overall Volume (2000-2015)
    • 10.2.1 Embolic Systems Volume (2000-2015)
    • 10.2.2 Navigational Systems Volume (2000-2015)
  • 10.3 Interventional Neurology Average Price (2000-2015)
  • 10.4 Interventional Neurology Distribution Share (2007-2008)
  • 10.5 Interventional Neurology, Canada, Company Share (2006-2007)
• 11 Neurostimulation Devices In Canada
  • 11.1 Neurostimulation Devices Overall Revenue (2000-2015)
  • 11.2 Neurostimulation Devices Overall Volume (2000-2015)
  • 11.3 Neurostimulation Devices Average Price (2000-2015)
  • 11.4 Neurostimulation Devices Distribution Share (2007-2008)
  • 11.5 Neurostimulation Devices, Canada, Company Share (2006-2007)
• 12 Neurosurgical Products In Canada
  • 12.1 Neurosurgical Products Overall Revenue (2000-2015)
  • 12.2 Neurosurgical Products Overall Volume (2000-2015)
  • 12.3 Neurosurgical Products Average Price (2000-2015)
  • 12.4 Neurosurgical Products Distribution Share (2007-2008)
  • 12.5 Neurosurgical Products, Canada, Company Share (2006-2007)
• 13 Radiosurgery In Canada
  • 13.1 Radiosurgery Overall Revenue (2000-2015)
  • 13.2 Radiosurgery Overall Volume (2000-2015)
  • 13.3 Radiosurgery Average Price (2000-2015)
  • 13.4 Radiosurgery Distribution Share (2007)
  • 13.5 Radiosurgery, Canada, Company Share (2007)
• 14 Overview of Key Companies in Canada Neurology Devices Market
  • 14.1 Boston Scientific Corporation
    • 14.1.1 Company Overview
    • 14.1.2 Value Chain Analysis
      • 14.1.2.1 Manufacturing
      • 14.1.2.2 Product Development
      • 14.1.2.3 Sales and Marketing
    • 14.1.3 Boston Scientific Corporation Pipeline Products
      • 14.1.3.1 Boston Scientific Corporation Pipeline Products By Equipment Type
      • 14.1.3.2 Boston Scientific Corporation Pipeline Products By Development Stage
      • 14.1.3.3 Boston Scientific Corporation Pipeline Products By Therapy Area
      • 14.1.3.4 Boston Scientific Corporation Pipeline Products By Clinical Trials
      • 14.1.3.5 Boston Scientific Corporation Pipeline Products By News Summary
  • 14.2 Medtronic, Inc
    • 14.2.1 Company Overview
    • 14.2.2 Value Chain Analysis
      • 14.2.2.1 Manufacturing
      • 14.2.2.2 Product Development
      • 14.2.2.3 Sales and Marketing
    • 14.2.3 Medtronic, Inc. Pipeline Products
      • 14.2.3.1 Medtronic, Inc. Pipeline Products By Equipment Type
      • 14.2.3.2 Medtronic, Inc. Pipeline Products By Development Stage
      • 14.2.3.3 Medtronic, Inc. Pipeline Products By Therapy Area
      • 14.2.3.4 Medtronic, Inc. Pipeline Products By Clinical Trials
      • 14.2.3.5 Medtronic, Inc. Pipeline Products By News Summary
  • 14.3 Elekta AB
    • 14.3.1 Company Overview
    • 14.3.2 Value Chain Analysis
      • 14.3.2.1 Manufacturing
      • 14.3.2.2 Product Development
      • 14.3.2.3 Sales and Marketing
    • 14.3.3 Elekta AB Pipeline Products
      • 14.3.3.1 Elekta AB Pipeline Products By Equipment Type
      • 14.3.3.2 Elekta AB Pipeline Products By Development Stage
      • 14.3.3.3 Elekta AB Pipeline Products By Therapy Area
      • 14.3.3.4 Elekta AB Pipeline Products By News Summary
  • 14.4 ev3 Inc
    • 14.4.1 Company Overview
    • 14.4.2 Value Chain Analysis
      • 14.4.2.1 Manufacturing
      • 14.4.2.2 Product Development
      • 14.4.2.3 Sales and Marketing
    • 14.4.3 ev3 Inc. Pipeline Products
      • 14.4.3.1 ev3 Inc. Pipeline Products By Equipment Type
      • 14.4.3.2 ev3 Inc. Pipeline Products By Development Stage
      • 14.4.3.3 ev3 Inc. Pipeline Products By Therapy Area
      • 14.4.3.4 ev3 Inc. Pipeline Products By Clinical Trials
      • 14.4.3.5 ev3 Inc. Pipeline Products By News Summary
  • 14.5 Cordis Corporation
    • 14.5.1 Company Overview
  • 14.6 Cyberonics, Inc
    • 14.6.1 Company Overview
    • 14.6.2 Cyberonics, Inc. Pipeline Products
      • 14.6.2.1 Cyberonics, Inc. Pipeline Products By Equipment Type
      • 14.6.2.2 Cyberonics, Inc. Pipeline Products By Development Stage
      • 14.6.2.3 Cyberonics, Inc. Pipeline Products By Therapy Area
  • 14.7 Codman & Shurtleff, Inc
    • 14.7.1 Company Overview
  • 14.8 Advanced Neuromodulation Systems, Inc
    • 14.8.1 Company Overview
  • 14.9 KARL STORZ GmbH & Co. KG
    • 14.9.1 Company Overview
  • 14.10 OLYMPUS CORPORATION
    • 14.10.1 Company Overview
    • 14.10.2 Value Chain Analysis
      • 14.10.2.1 Manufacturing
      • 14.10.2.2 Product Development
      • 14.10.2.3 Sales and Marketing
  • 14.11 Integra LifeSciences Holdings Corporation
    • 14.11.1 Company Overview
    • 14.11.2 Value Chain Analysis
      • 14.11.2.1 Manufacturing
      • 14.11.2.2 Product Development
      • 14.11.2.3 Sales and Marketing
• 15 Financial Deals Landscape
  • 15.1 Acquisition
    • 15.1.1 Alpine Biomed Acquires Stellate Systems
• 16 Appendix
  • 16.1 Global Markets Direct Research Methodology
  • 16.2 Coverage
  • 16.3 Secondary Research
  • 16.4 Primary Research
  • 16.5 Models
  • 16.6 Forecasts
  • 16.7 Expert Panel Validation
  • 16.8 Currency Conversion
  • 16.9 Contact Us
  • 16.10 Disclaimer
• 1 List of Tables
  • Table 1: Number of Physicians by Province in Canada, 2001 and 2005
  • Table 2: Hospital Wards by Specialty in Canada, 2003-2007
  • Table 3: Doctors by Specialty in Canada, 2003-2007
  • Table 4: Canada Healthcare Trade Statistics, 2001-2006
  • Table 5: Medical Equipment Classification in Canada, 2007
  • Table 6: Medical Equipment Licensing Fee in Canada, 2007
  • Table 7: Medical Equipment License Processing Duration in Canada, 2007
  • Table 8: Neurology Devices Cross Country Comparison, Revenue ($ mn), 2000-2015
  • Table 9: Neurology Devices, Canada, Overall Revenue ($ mn), 2000-2015
  • Table 10: Neurology Devices, Canada, Cross-Category Analysis, 2000-2015
  • Table 11: Neurology Devices, Canada, Overall Revenue ($ mn), Historic, 2000-2008
  • Table 12: Neurology Devices, Canada, Overall Revenue ($ mn), Forecast, 2008-2015
  • Table 13: Neurology Devices, Canada, Category Volume (Units), 2000-2015
  • Table 14: Neurology Devices, Canada, Category Volume (Units), Historic, 2000-2008
  • Table 15: Neurology Devices, Canada, Category Volume (Units), Forecast, 2008-2015
  • Table 16: Neurology Devices, Canada Company Share by Revenue ($ mn), 2006-2007
  • Table 17: CSF Management, Canada, Revenue ($ mn) by Segment, Historic, 2000-2008
  • Table 18: CSF Management, Canada, Revenue ($ mn) by Segment, Forecast, 2008-2015
  • Table 19: CSF Management, Canada, Volume (Units) by Segment, Historic, 2000-2008
  • Table 20: CSF Management, Canada, Volume (Units) by Segment, Forecast, 2008-2015
  • Table 21: CSF Management, Canada, Average Price ($), Historic, 2000-2008
  • Table 22: CSF Management, Canada, Average Price ($), Forecast, 2008-2015
  • Table 23: CSF Management, Canada, Distribution Share by Revenue ($mn), 2007-2008
  • Table 24: CSF Management, Canada, Company Share by Revenue ($ mn), 2006-2007
  • Table 25: Interventional Neurology, Canada, Revenue ($ mn) by Segment, Historic, 2000-2008
  • Table 26: Interventional Neurology, Canada, Revenue ($ mn) by Segment, Forecast, 2008-2015
  • Table 27: Embolic Systems, Canada, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
  • Table 28: Embolic Systems, Canada, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
  • Table 29: Navigational Systems, Canada, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
  • Table 30: Navigational Systems, Canada, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
  • Table 31: Interventional Neurology, Canada, Volume (Units) by Segment, Historic, 2000-2008
  • Table 32: Interventional Neurology, Canada, Volume (Units) by Segment, Forecast, 2008-2015
  • Table 33: Embolic Systems, Canada, Volume (Units) by Sub-Segment, Historic, 2000-2008
  • Table 34: Embolic Systems, Canada, Volume (Units) by Sub-Segment, Forecast, 2008-2015
  • Table 35: Navigational Systems, Canada, Volume (Units) by Sub-Segment, Historic, 2000-2008
  • Table 36: Navigational Systems, Canada, Volume (Units) by Sub-Segment, Forecast, 2008-2015
  • Table 37: Interventional Neurology, Canada, Average Price ($), Historic, 2000-2008
  • Table 38: Interventional Neurology, Canada, Average Price ($), Forecast, 2008-2015
  • Table 39: Interventional Neurology, Canada, Distribution Share by Revenue ($mn), 2007-2008
  • Table 40: Interventional Neurology, Canada, Company Share by Revenue ($ mn), 2006-2007
  • Table 41: Neurostimulation Devices, Canada, Revenue ($ mn) by Segment, Historic, 2000-2008
  • Table 42: Neurostimulation Devices, Canada, Revenue ($ mn) by Segment, Forecast, 2008-2015
  • Table 43: Neurostimulation Devices, Canada, Volume (Units) by Segment, Historic, 2000-2008
  • Table 44: Neurostimulation Devices, Canada, Volume (Units) by Segment, Forecast, 2008-2015
  • Table 45: Neurostimulation Devices, Canada, Average Price ($), Historic, 2000-2008
  • Table 46: Neurostimulation Devices, Canada, Average Price ($), Forecast, 2008-2015
  • Table 47: Neurostimulation Devices, Canada, Distribution Share by Revenue ($mn), 2007-2008
  • Table 48: Neurostimulation Devices, Canada, Company Share by Revenue ($ mn), 2006-2007
  • Table 49: Neurosurgical Products (Neuroendoscopes), Canada, Revenue ($ mn), Historic, 2000-2008
  • Table 50: Neurosurgical Products (Neuroendoscopes), Canada, Revenue ($ mn), Forecast, 2008-2015
  • Table 51: Neurosurgical Products (Neuroendoscopes), Canada, Volume (Units), Historic, 2000-2008
  • Table 52: Neurosurgical Products (Neuroendoscopes), Canada, Volume (Units), Forecast, 2008-2015
  • Table 53: Neurosurgical Products, Canada, Average Price ($), Historic, 2000-2008
  • Table 54: Neurosurgical Products, Canada, Average Price ($), Forecast, 2008-2015
  • Table 55: Neurosurgical Products, Canada, Distribution Share by Revenue ($mn), 2007-2008
  • Table 56: Neurosurgical Products, Canada, Company Share by Revenue ($ mn), 2006-2007
  • Table 57: Radiosurgery, Canada, Revenue ($ mn) by Segment, Historic, 2000-2008
  • Table 58: Radiosurgery, Canada, Revenue ($ mn) by Segment, Forecast, 2008-2015
  • Table 59: Radiosurgery, Canada, Volume (Units) by Segment, Historic, 2000-2008
  • Table 60: Radiosurgery, Canada, Volume (Units) by Segment, Forecast, 2008-2015
  • Table 61: Radiosurgery, Canada, Average Price ($), Historic, 2000-2008
  • Table 62: Radiosurgery, Canada, Average Price ($), Forecast, 2008-2015
  • Table 63: Table 64: Radiosurgery, Canada, Distribution Share by Revenue ($mn), 2007
  • Table 65: Radiosurgery, Canada, Company Share by Revenue ($ mn), 2007
  • Table 66: Boston Scientific Corporation Pipeline Products by Equipment Type
  • Table 67: Boston Scientific Corporation Pipeline Products By Development Stage
  • Table 68: Boston Scientific Corporation Pipeline Products By Therapy Area
  • Table 69: Boston Scientific Corporation Pipeline Products By Clinical Trials
  • Table 70: Boston Scientific Corporation Pipeline Products By News Summary
  • Table 71: Medtronic, Inc. Pipeline Products by Equipment Type
  • Table 72: Medtronic, Inc. Pipeline Products By Development Stage
  • Table 73: Medtronic, Inc. Pipeline Products By Therapy Area
  • Table 74: Medtronic, Inc. Pipeline Products By Clinical Trials
  • Table 75: Medtronic, Inc. Pipeline Products By News Summary
  • Table 76: Elekta AB Pipeline Products by Equipment Type
  • Table 77: Elekta AB Pipeline Products By Development Stage
  • Table 78: Elekta AB Pipeline Products By Therapy Area
  • Table 79: Elekta AB Pipeline Products By News Summary
  • Table 80: ev3 Inc. Pipeline Products by Equipment Type
  • Table 81: ev3 Inc. Pipeline Products By Development Stage
  • Table 82: ev3 Inc. Pipeline Products By Therapy Area
  • Table 83: ev3 Inc. Pipeline Products By Clinical Trials
  • Table 84: ev3 Inc. Pipeline Products By News Summary
  • Table 85: Cyberonics, Inc. Pipeline Products by Equipment Type
  • Table 86: Cyberonics, Inc. Pipeline Products By Development Stage
  • Table 87: Cyberonics, Inc. Pipeline Products By Therapy Area
  • Table 88: Alpine Biomed Acquires Stellate Systems
  • Table 89: USD to Local Currency, Average Exchange Rate 2008
• 1.2 List of Figures
  • Figure 1: Healthcare Financing in Canada, 2004
  • Figure 2: Healthcare Expenditure in Canada, 2000 - 2006
  • Figure 3: Neurology Devices Cross Country Comparison, Revenue ($ mn), 2000-2015
  • Figure 4: Neurology Devices, Canada, Overall Revenue ($ mn), 2000-2015
  • Figure 5: Neurology Devices, Canada, Cross-Category Analysis, 2000-2015
  • Figure 6: Neurology Devices, Canada, Overall Revenue ($ mn), Historic, 2000-2008
  • Figure 7: Neurology Devices, Canada, Overall Revenue ($ mn), Forecast, 2008-2015
  • Figure 8: Neurology Devices, Canada, Company Share (%), 2007
  • Figure 9: CSF Management, Canada, Revenue ($ mn) by Segment, Historic, 2000-2008
  • Figure 10: CSF Management, Canada, Revenue ($ mn) by Segment, Forecast, 2008-2015
  • Figure 11: CSF Management, Canada, Volume (Units) by Segment, Historic, 2000-2008
  • Figure 12: CSF Management, Canada, Volume (Units) by Segment, Forecast, 2008-2015
  • Figure 13: CSF Management, Canada, Company Share (%), 2007
  • Figure 14: Interventional Neurology, Canada, Revenue ($ mn) by Segment, Historic, 2000-2008
  • Figure 15: Interventional Neurology, Canada, Revenue ($ mn) by Segment, Forecast, 2008-2015
  • Figure 16: Embolic Systems, Canada, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
  • Figure 17: Embolic Systems, Canada, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
  • Figure 18: Navigational Systems, Canada, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
  • Figure 19: Navigational Systems, Canada, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
  • Figure 20: Interventional Neurology, Canada, Volume (Units) by Segment, Historic, 2000-2008
  • Figure 21: Interventional Neurology, Canada, Volume (Units) by Segment, Forecast, 2008-2015
  • Figure 22: Embolic Systems, Canada, Volume (Units) by Sub-Segment, Historic, 2000-2008
  • Figure 23: Embolic Systems, Canada, Volume (Units) by Sub-Segment, Forecast, 2008-2015
  • Figure 24: Navigational Systems, Canada, Volume (Units) by Sub-Segment, Historic, 2000-2008
  • Figure 25: Navigational Systems, Canada, Volume (Units) by Sub-Segment, Forecast, 2008-2015
  • Figure 26: Interventional Neurology, Canada, Company Share (%), 2007
  • Figure 27: Neurostimulation Devices, Canada, Revenue ($ mn) by Segment, Historic, 2000-2008
  • Figure 28: Neurostimulation Devices, Canada, Revenue ($ mn) by Segment, Forecast, 2008-2015
  • Figure 29: Neurostimulation Devices, Canada, Volume (Units) by Segment, Historic, 2000-2008
  • Figure 30: Neurostimulation Devices, Canada, Volume (Units) by Segment, Forecast, 2008-2015
  • Figure 31: Neurostimulation Devices, Canada, Company Share (%), 2007
  • Figure 32: Neurosurgical Products (Neuroendoscopes), Canada, Revenue ($ mn), Historic, 2000-2008
  • Figure 33: Neurosurgical Products (Neuroendoscopes), Canada, Revenue ($ mn), Forecast, 2008-2015
  • Figure 34: Neurosurgical Products (Neuroendoscopes), Canada, Volume (Units), Historic, 2000-2008
  • Figure 35: Neurosurgical Products (Neuroendoscopes), Canada, Volume (Units), Forecast, 2008-2015
  • Figure 36: Neurosurgical Products, Canada, Company Share (%), 2007
  • Figure 37: Radiosurgery, Canada, Revenue ($ mn) by Segment, Historic, 2000-2008
  • Figure 38: Radiosurgery, Canada, Revenue ($ mn) by Segment, Forecast, 2008-2015
  • Figure 39: Radiosurgery, Canada, Volume (Units) by Segment, Historic, 2000-2008
  • Figure 40: Radiosurgery, Canada, Volume (Units) by Segment, Forecast, 2008-2015
  • Figure 41: Boston Scientific Corporation Value Chain Analysis
  • Figure 42: Medtronic, Inc. Value Chain Analysis
  • Figure 43: Elekta AB Value Chain Analysis
  • Figure 44: ev3 Inc. Value Chain Analysis
  • Figure 45: Olympus Medical Systems Corp. Value Chain Analysis
  • Figure 46: Integra LifeSciences Holdings Corporation Value Chain Analysis
  • Figure 47: Global Markets Direct Methodology